Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors

Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors Descriptor: 3-[4-[6-chloranyl-5-[[(3R)-pyrrolidin-3-yl]amino]-1H-indazol-3-yl]pyrazol-1-yl]benzenecarbonitrile, Tyrosine-protein kinase Mer Authors: Anantharajan, J, Baburajendran, N. Deposit date: 2021-01-19 Release date: 2021-10-13 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (3.146 Å) Cite: Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors. Bioorg.Med.Chem., 49, 2021基于片段的吲唑类化合物作为AXL激酶抑制剂的先导发现研究 描述物：3-[4-[6-氯-5-[[(3R)-吡咯烷-3-基]氨基]-1H-吲唑-3-基]吡唑-1-基]苯甲腈、酪氨酸蛋白激酶Mer 作者：Anantharajan J、Baburajendran N 提交日期：2021-01-19 发布日期：2021-10-13 最后修改日期：2023-11-29 实验方法：X射线衍射（3.146 Å） 引用文献：Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors. Bioorg.Med.Chem., 49, 2021